We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Peroxide Battles Hospital-Acquired Infections

By HospiMedica staff writers
Posted on 01 Nov 2007
A hydrogen-peroxide based device sterilizes exposed pre-cleaned surfaces in a closed environment, effectively eradicating almost all bacteria, viruses, and microbes.

The VaproSure Sterilizer is a low temperature dry vapor advanced room sterilization system that destroys the full spectrum of biological contaminants (spores, bacteria (including Methicillin-resistant Staphylococcus aureus (MRSA), viruses, and fungi), leaving no residue or odor. More...
Mounted on a cart, the box-shaped self-contained system utilizes the proprietary Vaprox hydrogen peroxide sterilant, resulting in only water and oxygen as by-products of the decontamination process. The sterilization process itself involves four stages: dehumidification, room conditioning, sterilization, and aeration.

The device includes a desiccant system for the continuous dehumidification of the targeted room; a desiccant dryer regenerator to dry and re-use the desiccant system; an air circulation system for the efficient distribution of sterilant vapor; an auxiliary high capacity aeration system to destroy sterilant vapor at the conclusion of the sterilization cycle; and sensors that continuously monitors room temperature, humidity, and the concentration of sterilant in the air. The Sterilizer is capable of automated and remote operation via wireless technology.

Both the VaproSure Sterilizer and Vaprox are products of Steris (Mentor, OH, USA), and have been approved by the U.S. Food and Drug Administration (FDA) and the U.S. Environmental Protection Agency (EPA).

The Journal of the American Medical Association (JAMA) reported that
hospital-acquired infections killed nearly 19,000 people in the United States in 2005. Other studies have shown that these infections are the eighth leading cause of death in
the U.S., more than AIDS, homicides, automobile accidents, and most forms of cancer.


Related Links:
Steris

Gold Member
12-Channel ECG
CM1200B
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Mammo DR Retrofit Solution
DR Retrofit Mammography
Surgical Headlight
IsoTorch
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The fiber in the brain implant is less than half a millimeter thick (Photo courtesy of Peter Aagaard Brixen)

Brain Implant Records Neural Signals and Delivers Precise Medication

Neurological diseases such as epilepsy involve complex interactions across multiple layers of the brain, yet current implants can typically stimulate or record activity from only a single point.... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.